D
Daniel Tian Li
Researcher at Heidelberg University
Publications - 3
Citations - 603
Daniel Tian Li is an academic researcher from Heidelberg University. The author has contributed to research in topics: Internal medicine & Antibody. The author has an hindex of 2, co-authored 2 publications receiving 474 citations.
Papers
More filters
Journal ArticleDOI
Atlas of the clinical genetics of human dilated cardiomyopathy
Jan Haas,Karen S. Frese,Barbara Peil,Wanda Kloos,Andreas Keller,Rouven Nietsch,Zhu Feng,Sabine Müller,Elham Kayvanpour,Britta Vogel,Farbod Sedaghat-Hamedani,Wei Keat Lim,Xiaohong Zhao,Dmitriy Fradkin,Doreen Köhler,Simon Fischer,Jennifer Franke,Sabine Marquart,Ioana Barb,Daniel Tian Li,Ali Amr,Philipp Ehlermann,Derliz Mereles,Tanja Weis,Sarah Hassel,Andreas Kremer,Vanessa King,Emil Wirsz,Emil Wirsz,Richard Isnard,Michel Komajda,Alessandra Serio,Maurizia Grasso,Petros Syrris,Eleanor Wicks,Vincent Plagnol,Luis R. Lopes,Tenna Gadgaard,Hans Eiskjær,Mads E. Jørgensen,Diego García-Giustiniani,Martin Ortiz-Genga,María G. Crespo-Leiro,Rondal H Lekanne Dit Deprez,Imke Christiaans,Ingrid A.W. van Rijsingen,Arthur A.M. Wilde,Anders Waldenström,Martino Bolognesi,Riccardo Bellazzi,Stellan Mörner,Justo Lorenzo Bermejo,Lorenzo Monserrat,Eric Villard,Jens Mogensen,Yigal M. Pinto,Philippe Charron,Perry M. Elliott,Eloisa Arbustini,Hugo A. Katus,Benjamin Meder +60 more
TL;DR: This is to the authors' knowledge, the first study that comprehensively investigated the genetics of DCM in a large-scale cohort and across a broad gene panel of the known DCM genes and underline the high analytical quality and feasibility of Next-Generation Sequencing in clinical genetic diagnostics.
Journal ArticleDOI
Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.
Farbod Sedaghat-Hamedani,Jan Haas,Feng Zhu,Feng Zhu,Christian Geier,Elham Kayvanpour,Martin Liss,Alan Lai,Karen S. Frese,Regina Pribe-Wolferts,Ali Amr,Daniel Tian Li,Omid Shirvani Samani,Avisha Carstensen,Diana Martins Bordalo,Marion Müller,Christine Fischer,Jing Shao,Jing Wang,Ming Nie,Li Yuan,Sabine Haßfeld,Christine Schwartz,Min Zhou,Zihua Zhou,Yan-Wen Shu,Min Wang,Kai Huang,Qiutang Zeng,Long-Xian Cheng,Tobias Fehlmann,Philipp Ehlermann,Andreas Keller,Christoph Dieterich,Katrin Streckfuß-Bömeke,Yuhua Liao,Michael Gotthardt,Hugo A. Katus,Benjamin Meder +38 more
TL;DR: The data demonstrate that the clinical course of symptomatic LVNC can be severe and the identified pathogenic variants and distribution of disease genes-a titin-related pathomechanism is found in every fourth patient-should be considered in genetic counselling of patients.
Journal ArticleDOI
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond
TL;DR: There is a marked improvement in heart and multi-organ transplant outcomes over the past 10 years with newer treatments and improvements in support with temporary and durable mechanical circulatory support while awaiting transplant.